Received: 24 July 2022
Accepted: 28 February 2023
First Online: 27 March 2023
: Ethics approval was obtained from the local scientific committee, within the extended informed consent procedures activated during the early COVID-19 epidemic. The research was carried out in accordance with Helsinki Declaration for patients’ safety. No additional samplings were made, and all biological tests were performed using the leftovers of routine EDTA samples for full blood count.
: The consent for publication was expressly included in a section of the informed consent prepared during the early COVID-19 epidemic, and signed by patients—where applicable—or by their representatives.
: The authors declare that they have no competing interests.